Estrogen receptor

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Estrogen receptor, abbreviated ER, is a common immunostain.

General

In the context of breast pathology it is a class II IHC test, as it is used for treatment decisions by itself.^[1]

Positive

Breast carcinoma - most.
- Ductal carcinoma in situ - most.
- Invasive lobular breast carcinoma - all.
- Invasive ductal carcinoma of breast - most.
Endometrial carcinomas.

Negative

Endocervical adenocarcinoma.

References

↑ Torlakovic, EE.; Riddell, R.; Banerjee, D.; El-Zimaity, H.; Pilavdzic, D.; Dawe, P.; Magliocco, A.; Barnes, P. et al. (Mar 2010). "Canadian Association of Pathologists-Association canadienne des pathologistes National Standards Committee/Immunohistochemistry: best practice recommendations for standardization of immunohistochemistry tests.". Am J Clin Pathol 133 (3): 354-65. doi:10.1309/AJCPDYZ1XMF4HJWK. PMID 20154273.

[pmid20154273-1] Torlakovic, EE.; Riddell, R.; Banerjee, D.; El-Zimaity, H.; Pilavdzic, D.; Dawe, P.; Magliocco, A.; Barnes, P. et al. (Mar 2010). "Canadian Association of Pathologists-Association canadienne des pathologistes National Standards Committee/Immunohistochemistry: best practice recommendations for standardization of immunohistochemistry tests.". Am J Clin Pathol 133 (3): 354-65. doi:10.1309/AJCPDYZ1XMF4HJWK. PMID 20154273.

[1]

Estrogen receptor

Contents

General

Positive

Negative

See also

References

Navigation menu

Search